Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
22 01 2019
Historique:
received: 19 09 2018
accepted: 13 12 2018
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 10 1 2020
Statut: ppublish

Résumé

In the earliest phase of inflammation, histamine and other agonists rapidly mobilize P-selectin to the apical membranes of endothelial cells, where it initiates rolling adhesion of flowing neutrophils. Clustering of P-selectin in clathrin-coated pits facilitates rolling. Inflammatory cytokines typically signal by regulating gene transcription over a period of hours. We found that neutrophils rolling on P-selectin secreted the cytokine oncostatin M (OSM). The released OSM triggered signals through glycoprotein 130 (gp130)-containing receptors on endothelial cells that, within minutes, further clustered P-selectin and markedly enhanced its adhesive function. Antibodies to OSM or gp130, deletion of the gene encoding OSM in hematopoietic cells, or conditional deletion of the gene encoding gp130 in endothelial cells inhibited neutrophil rolling on P-selectin in trauma-stimulated venules of the mouse cremaster muscle. In a mouse model of P-selectin-dependent deep vein thrombosis, deletion of OSM in hematopoietic cells or of gp130 in endothelial cells markedly inhibited adhesion of neutrophils and monocytes and the rate and extent of thrombus formation. Our results reveal a paracrine-signaling mechanism by which neutrophil-released OSM rapidly influences endothelial cell function during physiological and pathological inflammation.

Identifiants

pubmed: 30670533
pii: bloodadvances.2018026294
doi: 10.1182/bloodadvances.2018026294
pmc: PMC6341191
doi:

Substances chimiques

Biomarkers 0
IL6ST protein, human 0
P-Selectin 0
Oncostatin M 106956-32-5
Cytokine Receptor gp130 133483-10-0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-183

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM114731
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL034363
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128390
Pays : United States

Informations de copyright

© 2019 by The American Society of Hematology.

Références

J Immunol. 1991 Oct 1;147(7):2175-80
pubmed: 1918953
Am J Physiol. 1994 Sep;267(3 Pt 2):H1017-23
pubmed: 7522403
Br J Haematol. 1996 Dec;95(3):443-51
pubmed: 8943882
Blood. 2011 Jan 27;117(4):1350-8
pubmed: 20980678
Am J Pathol. 2001 Oct;159(4):1531-9
pubmed: 11583979
Dev Dyn. 2006 Dec;235(12):3413-22
pubmed: 17072878
J Immunol. 1987 Nov 1;139(9):2977-83
pubmed: 3117884
J Immunol. 2008 Apr 15;180(8):5575-81
pubmed: 18390742
Blood. 1997 Jul 1;90(1):165-73
pubmed: 9207450
Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L1096-103
pubmed: 19304908
Mol Biol Cell. 1993 Aug;4(8):791-801
pubmed: 7694691
J Exp Med. 1996 Jan 1;183(1):57-65
pubmed: 8551244
Cardiovasc Res. 2015 Aug 1;107(3):331-9
pubmed: 25994174
Blood. 1999 Feb 15;93(4):1413-21
pubmed: 9949186
J Cell Biol. 1998 Aug 10;142(3):859-71
pubmed: 9700172
Am J Physiol Cell Physiol. 2006 Jul;291(1):C18-26
pubmed: 16452159
J Invest Dermatol. 2006 Mar;126(3):628-37
pubmed: 16410783
Blood. 2000 Nov 1;96(9):3070-7
pubmed: 11049986
Blood. 2018 Sep 27;132(13):1426-1437
pubmed: 30068506
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4072-7
pubmed: 11274431
Blood. 2013 Nov 28;122(23):3832-42
pubmed: 24081661
J Biol Chem. 1997 Nov 7;272(45):28750-6
pubmed: 9353345
J Exp Med. 1996 Jul 1;184(1):81-92
pubmed: 8691152
Annu Rev Biochem. 1997;66:511-48
pubmed: 9242916
J Immunol. 2002 Nov 1;169(9):5244-51
pubmed: 12391243
Nature. 2003 May 8;423(6936):190-3
pubmed: 12736689
J Cell Biol. 1991 Oct;115(1):223-34
pubmed: 1717478
J Exp Med. 2000 Apr 17;191(8):1413-22
pubmed: 10770806
Biophys J. 1993 Oct;65(4):1560-9
pubmed: 7506064
Blood. 2011 Jan 27;117(4):1400-7
pubmed: 20959603
Eur J Immunol. 1994 Dec;24(12):3019-24
pubmed: 7528665
Nat Commun. 2017 May 12;8:15196
pubmed: 28497779
Nature. 1990 Feb 22;343(6260):757-60
pubmed: 1689464
J Immunol. 1999 May 1;162(9):5547-55
pubmed: 10228036
Nat Med. 2011 May;17(5):581-8
pubmed: 21516086
J Clin Invest. 1997 Jul 1;100(1):158-68
pubmed: 9202068
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
J Biol Chem. 1989 May 15;264(14):7768-71
pubmed: 2470733
Am J Physiol Cell Physiol. 2011 Oct;301(4):C947-53
pubmed: 21775705
J Biol Chem. 1993 Jul 15;268(20):15229-37
pubmed: 7686912
J Immunol. 2015 Oct 15;195(8):3880-9
pubmed: 26355151
J Cell Biol. 1989 Feb;108(2):389-400
pubmed: 2563728
J Allergy Clin Immunol. 2016 Jul;138(1):187-199
pubmed: 26948077
J Biol Chem. 1984 Aug 10;259(15):9799-804
pubmed: 6746667
J Exp Med. 2015 Jul 27;212(8):1267-81
pubmed: 26169939
Blood Adv. 2018 Apr 10;2(7):731-744
pubmed: 29592875
Blood. 2011 Dec 22;118(26):6743-51
pubmed: 22021370
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10166-71
pubmed: 11481445
J Cell Biol. 2003 Dec 22;163(6):1385-95
pubmed: 14676308
J Exp Med. 2007 Apr 16;204(4):793-804
pubmed: 17389238
J Biol Chem. 1984 Jul 25;259(14):9121-6
pubmed: 6746643
J Biol Chem. 1995 Nov 10;270(45):26818-26
pubmed: 7592923
Annu Rev Cell Dev Biol. 2010;26:363-96
pubmed: 19575676
Int J Hematol. 2006 Nov;84(4):319-27
pubmed: 17118758
Blood. 2008 Sep 1;112(5):2035-45
pubmed: 18550846
Circ Res. 2017 Sep 29;121(8):941-950
pubmed: 28739590
J Clin Invest. 1989 Jul;84(1):92-9
pubmed: 2472431
Front Immunol. 2012 Jun 12;3:157
pubmed: 22701459
Blood. 1989 Apr;73(5):1109-12
pubmed: 2467701
Annu Rev Immunol. 2012;30:459-89
pubmed: 22224774
J Exp Med. 1998 Nov 16;188(10):1955-65
pubmed: 9815272
Nat Rev Immunol. 2007 Sep;7(9):678-89
pubmed: 17717539
Nat Immunol. 2010 Apr;11(4):328-34
pubmed: 20208538
Blood. 2016 Jul 28;128(4):529-41
pubmed: 27235139
Immunol Rev. 2016 Sep;273(1):11-28
pubmed: 27558325
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
J Clin Invest. 2002 Apr;109(7):939-50
pubmed: 11927621
Blood. 2017 Jul 13;130(2):181-191
pubmed: 28515093
Immunity. 1994 Nov;1(8):709-20
pubmed: 7541306
Nat Commun. 2015 Apr 20;6:6915
pubmed: 25892652
Cytokine Growth Factor Rev. 2015 Oct;26(5):545-58
pubmed: 26198770
J Cell Biol. 1995 Feb;128(4):661-71
pubmed: 7532174

Auteurs

Hendra Setiadi (H)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.

Tadayuki Yago (T)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.

Zhenghui Liu (Z)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.

Rodger P McEver (RP)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; and.
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH